Inventor · disambiguated record
Martin Quibell
Also filed as: QUIBELL MARTIN
23 granted patents·25 pending applications·64 citations·filing 1996–2024
93Inventor score
Files withAMURA THERAPEUTICS LTD23GREY WOLF THERAPEUTICS LTD6QUIBELL MARTIN4ACADIA PHARM INC3PEPTIDE THERAPEUTICS LTD3
Top patents by PatentIndex Score
48 records- 0178US8933109B2Furo[3, 2-B] pyrrol-3-ones as cathespin S inhibitorsAMURA THERAPEUTICS LTD·Filed 2013·Granted Jan 13, 2015·3 cites·54 claims
- 0277US7799791B2Tetrahydrofuro(3,2-B) pyrrol-3-one derivatives as inhibitors of cysteine proteinasesAMURA THERAPEUTICS LTD·Filed 2009·Granted Sep 21, 2010·3 cites·17 claims
- 0375US7846935B2Furo[3,2-B]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitorsAMURA THERAPEUTICS LTD·Filed 2009·Granted Dec 7, 2010·2 cites·12 claims
- 0475US7803803B2Tetrahydrofuro[3,2-B] pyrrol-3-ones as cathepsin K inhibitorsAMURA THERAPEUTICS LTD·Filed 2009·Granted Sep 28, 2010·2 cites·19 claims
- 0573US6034066ACysteine protease inhibitors for use in treatment of IGE mediated allergic diseasesPEPTIDE THERAPEUTICS LTD·Filed 1996·Granted Mar 7, 2000·31 cites·14 claims
- 0672US8008290B2CompoundsAMURA THERAPEUTICS LTD·Filed 2010·Granted Aug 30, 2011·3 cites·39 claims
- 0769US8501744B2Piperazine compoundsQUIBELL MARTIN·Filed 2010·Granted Aug 6, 2013·1 cites·15 claims
- 0868US8389737B2Furo[3, 2-B] pyrrol-3-ones as cathespin S inhibitorsQUIBELL MARTIN·Filed 2010·Granted Mar 5, 2013·1 cites·15 claims
- 0967US2024366595A1Phenyl-sulfamoyl.benzoyc acids as erap1 modulatorsGREY WOLF THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 1064US6958358B2Inhibitors of cruzipain and other cysteine proteasesAMURA THERAPEUTICS LTD·Filed 2002·Granted Oct 25, 2005·4 cites·35 claims
- 1163US7737150B2Furo[3, 2-b] pyrrol derivativesAMURA THERAPEUTICS LTD·Filed 2009·Granted Jun 15, 2010·0 cites·14 claims
- 1263US2015164912A1Furo[3, 2-b] pyrr0l-3-ones as cathespin s inhibitorsAMURA THERAPEUTICS LTD·Filed 2014·Application pending·0 cites
- 1361US7132449B2Inhibitors of cruzipain and other cysteine proteasesAMURA THERAPEUTICS LTD·Filed 2002·Granted Nov 7, 2006·1 cites·35 claims
- 1460US2025367158A1Modulators of g protein-coupled receptor 88ACADIA PHARM INC·Filed 2023·Application pending·0 cites
- 1560US2025367143A1Modulators of g protein-coupled receptor 88ACADIA PHARM INC·Filed 2023·Application pending·0 cites
- 1659US9045492B2Piperazine compoundsAMURA THERAPEUTICS LTD·Filed 2013·Granted Jun 2, 2015·0 cites·39 claims
- 1759US8552202B2Furo[3, 2-B] pyrrol-3-ones as cathespin S inhibitorsAMURA THERAPEUTICS LTD·Filed 2013·Granted Oct 8, 2013·0 cites·31 claims
- 1859US7846934B2Furo[3,2-B] pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitorsAMURA THERAPEUTICS LTD·Filed 2009·Granted Dec 7, 2010·0 cites·15 claims
- 1957US2016361295A1Furo[3, 2-b] pyrr0l-3-ones as cathespin s inhibitorsAMURA THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
- 2057US2009247471A1Inhibitors of cruzipain and other cysteine proteasesAMURA THERAPEUTICS LTD·Filed 2008·Application pending·0 cites
- 2156US2024376046A1Phenyl-sulfamoyl-benzoic acid derivatives as erap1- modulatorsGREY WOLF THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 2255US6528275B1Substrates and inhibitors of proteolytic enzymesMEDIVIR UK LTD·Filed 1997·Granted Mar 4, 2003·10 cites·10 claims
- 2354US2016015685A1Furo [3, 2-b] pyrr0l-3-0nes as cathespin s inhibitorsAMURA THERAPEUTICS LTD·Filed 2015·Application pending·0 cites
- 2453US2004229915A1Cysteine protease inhibitorsMEDIVIR AB·Filed 2004·Application pending·0 cites
- 2552US12023333B2Phenyl-sulfamoyl.benzoyc acids as ERAP1 modulatorsGREY WOLF THERAPEUTICS LTD·Filed 2020·Granted Jul 2, 2024·0 cites·11 claims
- 2651US2005070598A1Cysteine protease inhibitorsMEDIVIR AB·Filed 2003·Application pending·0 cites
- 2751US2008213297A1Method of producing conjugate vaccinesAMURA THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 2851US2024132450A1Modulators of g protein-coupled receptor 88ACADIA PHARM INC·Filed 2021·Application pending·0 cites
- 2950US2005020588A1Cysteine protease inhibitorsFiled 2004·Application pending·0 cites
- 3049US8877927B2Furo[3,2-B] pyrrol -3-one derivatives and their use as cysteinyl proteinase inhibitorsQUIBELL MARTIN·Filed 2009·Granted Nov 4, 2014·0 cites·27 claims
- 3149US2024300976A1Compounds as modulators of endoplasmic reticulum aminopeptidase 1 (erap1)GREY WOLF THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 3248US8053437B2Furo[3. 2-B] pyrrol derivativesAMURA THERAPEUTICS LTD·Filed 2010·Granted Nov 8, 2011·0 cites·5 claims
- 3348US8039641B2Tetrahydrofuro[3,2-b] pyrrol-3-one intermediatesAMURA THERAPEUTICS LTD·Filed 2009·Granted Oct 18, 2011·0 cites·6 claims
- 3447US12377084B2ERAP1 modulatorsGREY WOLF THERAPEUTICS LTD·Filed 2020·Granted Aug 5, 2025·0 cites·20 claims
- 3547US7425562B2Inhibitors of cruzipain and other cysteine proteasesAMURA THERAPEUTICS LTD·Filed 2002·Granted Sep 16, 2008·0 cites·29 claims
- 3647US2003186962A1Cysteine protease inhibitorsFiled 2001·Application pending·0 cites
- 3747US2015209349A1Piperazine CompoundsAMURA THERAPEUTICS LTD·Filed 2015·Application pending·0 cites
- 3846US2022106595A1Antibacterial antisense agentsPEDANIUS THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 3945US6372885B1Solid-phase technology for the preparation of amidesPEPTIDE THERAPEUTICS LTD·Filed 1997·Granted Apr 16, 2002·3 cites·6 claims
- 4045US2003092067A1Substrates and inhibitors of proteolytic enzymesPEPTIDE THERAPEUTICS LTD·Filed 2002·Application pending·0 cites
- 4144US12485169B2CompoundsGREY WOLF THERAPEUTICS LTD·Filed 2019·Granted Dec 2, 2025·0 cites·11 claims
- 4244US2009131502A1Biologically active compoundsQUIBELL MARTIN·Filed 2008·Application pending·0 cites
- 4344US2003203900A1Cysteine protease inhibitorsFiled 2001·Application pending·0 cites
- 4441US2006100431A1Biologically active compoundsAMURA THERAPEUTICS LTD·Filed 2003·Application pending·0 cites
- 4540US2009005575A1Preparation of diazapentalene derivatives via epoxydation of dihydropyrrolesAMURA THERAPEUTICS LTD·Filed 2008·Application pending·0 cites
- 4638US2004127549A1Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteasesFiled 2002·Application pending·0 cites
- 4736US2005158370A1Charge-balanced chemoselective linkersAMURA THERAPEUTICS LTD·Filed 2003·Application pending·0 cites
- 4832US2012202756A1Use of prodrugs to avoid gi mediated adverse eventsFRANKLIN RICHARD·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martin Quibell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →